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of the T cell response to IAV has been highlighted in studies using the mouse as a host 102 (26, 31, 40) . However, the rapidity with which IAVs, especially of newly-emerged highly 103 pathogenic strains, induce pathology, suggests that innate immunity is also likely to be a 104 main contributor (36, 44, 62 Total RNA was extracted from whole tissues using TRI reagent (Sigma-Aldrich), and 175 was subsequently used for cDNA synthesis, with the Omniscript reverse transcription kit 176 (Qiagen, Hilden, Germany). Briefly, 1ng of RNA was used as template and cDNA 177 synthesis was primed by a mixture of 1uM random hexamers and 1uM of a primer 178 specific to a highly conserved region of IAV matrix gene (5'-179 TCTAACCGAGGTCGAAACGTA-3'), as previously described (66). Reactions were 180 incubated at 37°C for 1 hour and terminated by incubating the mixture at 90°C for 5 min. To facilitate the study of the innate response to IAV infection and the potential direct 229 effect of Treg cell on innate immunity, we have used lymphocyte-deficient Rag1 -/-mice 230 as hosts, in which a confounding effect of adaptive immunity was absent. PR8-infected 231
Rag1
-/-mice started losing body weight, which was used as a measure of pathology, on 232 average from day 7 of infection and reached an end-point of 25% body weight loss, at 233 which they were culled, in a median of 17.8 days (Fig. 1A ). Viral replication in the lungs, 234 assessed by qRT-PCR for matrix mRNA, was very high from the onset of symptoms and, 235 as expected in lymphocyte-deficient hosts, remained high throughout the course of 236 infection (Fig. 1B) . In the absence of an adaptive immune response, IAV could have the 237 potential to spread beyond the lungs and thus cause mortality due to systemic 238 manifestations. We therefore looked for the presence of viral mRNA in organs other than 239 the lungs. Indeed, PR8 matrix mRNA was readily detected in the circulation and in all 240 organs tested (Fig. 1C) . However, the relative presence of PR8 matrix mRNA was at least 241 one order of magnitude higher in the lungs than any other anatomical location (Fig. 1C) , 242 indicating that IAV was replicating primarily in the lungs. In addition, we were unable to 243 isolate infectious particles of PR8 from any location other than the lungs (data not 244 shown), suggesting that the systemic presence of viral RNA was not associated with 245 productive infection. As it was important to establish that the pathology developing 246 during IAV infection of Rag1 -/-mice was due to viral replication in the lungs, we 247 Table S1 in 298 the supplemental material). Interestingly, some of the most highly (Fig. 4B ). These cells were most closely related to the monocyte/macrophage 309 lineage, as they expressed high levels of CD11b and Gr1 (Ly-6C + , but Ly-6G -), 310 intermediate levels of CD11c, and were also positive for MHC class II and F4/80 (Fig.  311   4C) . 312
We next investigated the effect of Treg cell transfer on lung monocytosis in PR8-infected 313
-/-mice throughout the course of infection. Monocyte/macrophage numbers rose 314 steadily in the lungs of PR8-infected Rag1 -/-mice from day 7 post infection until 315 termination of the experiment, in comparison with uninfected mice (Fig. 5A) . (Fig. 5A ). This delay 318 was also evident at late time points (p=0.006 post day 20) (Fig. 5A) , when disease 319 severity in PR8-infected Rag1 -/-recipients of Treg cells approached that of control mice. 320
Thus, Treg cells significantly reduced lung monocytosis throughout PR8 infection of 321
-/-mice, even though these mice did eventually succumb to severe IAV-induced 322 pathology. Histological examination of lung sections revealed that, in comparison with 323 those from uninfected control mice, the lungs of PR8-infected Rag1 -/-mice were 324 noticeably more inflamed, independently of the presence of Treg cells (Fig. 5B) . 325
However, this lung inflammation and mononuclear cell infiltration were more localized 326 and confined to distinct areas in mice that had received Treg cells than in those that had 327 not, where mononuclear cell infiltrates were distributed evenly throughout the tissue ( 
-/-mice, in comparison with uninfected controls (see Table. S1 in the 341 supplemental material, Fig. 6A ). Comparison between PR8-infected Rag1 -/-mice that had 342 received Treg cells and those that did not, revealed that Treg cell transfer significantly 343 affected the expression of only approximately 75 genes (see Table. S2 in the 344 supplemental material). Importantly, Ccl8 induction by IAV infection was substantially 345 suppressed by Treg cells (Fig. 6A) . Furthermore, this suppression was specific for Ccl8 346 and one other chemokine, chemokine (C-X-C motif) ligand 13 (Cxcl13), as Treg cell 347 transfer did not significantly affect the induction of any other chemokine detected in PR8-348 infected lungs (Fig. 6A) . The effect of Treg cells on Ccl8 gene expression in the lungs of 349 PR8-infected mice was further validated with qRT-PCR analysis, which revealed that at 350 early time points (d15-19) Treg cells suppressed the induction of Ccl8 transcription by 351 PR8 infection to levels comparable to those seen in uninfected mice (Fig. 6B) . However, 352
Ccl8 transcription was strongly induced in the lungs of PR8-infected Rag1 -/-mice at later 353 time points (d20-26), independently of the presence of Treg cells (Fig. 6B) Table. S2 in the 364 supplemental material, Fig. 6A) . Similarly, serum levels of CCL2/MCP-1 were strongly 365 upregulated by PR8 infection, and were not affected by Treg cells (Fig. 6E) . In contrast, 366 serum levels of CCL8/MCP-2 were readily detectable in uninfected controls and were 367 unaffected by either PR8 infection or Treg cell transfer (Fig. 6D) . Thus, the effect of Treg 368 cells on chemokine expression appeared to be specific for CCL8/MCP-2 and for the lung 369 Treg cells were virtually disease-free and their body weight did not change significantly 388 (Fig. 7A) . The disease-preventing effect of Treg cell transfer was not mediated by 389 enhancement of the T cell-independent neutralizing antibody response in recipient mice. 390
Whereas virus-neutralizing serum antibodies were not detected in C-Foxn1 nu mice prior 391 to PR8 infection, these mice mounted an antibody response of similar neutralizing 392 activity to that of wild-type control mice 6 days post PR8 infection (Fig. 7B) 
(26). 393
Transfer of Treg cells into PR8-infected C-Foxn1 nu mice led to a significant suppression 394 of this early T cell-independent antibody response (Fig. 7B) . On day 12 post PR8 395 infection, when wild-type mice showed a strong T cell-dependent antibody response, 396 neutralizing antibody titers were comparably low in C-Foxn1 nu mice whether or not they 397 had received Treg cells (Fig. 7B) showed that lack of IL-10 decreased mortality and delayed death following lethal IAV 588 infection, whereas no effect of IL-10 could be demonstrated following sublethal IAV 589 infection (38). Together these studies, suggest that effector T cell-derived IL-10 may be 590 harmful, neutral or beneficial in the host response to IAV infection, depending on many, 591 ill-defined parameters. Nevertheless, our results indicated that Treg cell-derived IL-10 592 was dispensable in the suppression of innate pathology by Treg cells following PR8 593 infection of Rag1 -/-mice. Similarly, whereas a crucial contribution of IL-35 in the 594 suppression of T cell-driven pathology has been suggested by one study (9), we were 595 unable to demonstrate any requirement for Treg cell-produced IL-35 in this system. In 596 addition to production of IL-10 and IL-35, Treg cells have been shown to use various 597 other mediators for their suppression (56, 65). Precisely which of these mediators, in 598 isolation or in combination, contribute to the suppression of innate immune pathology in 599 IAV mice by Treg cells, will require further study. 600
It is important to note that although adoptive transfer of Treg cells into PR8-infected 601
Rag1
-/-mice significantly delayed the onset of pathology and clinical symptoms, it did 602 not prevent the eventual development of severe pathology and disease in these mice. 
